Cargando…

Therapy drives genomic evolution in metastatic cancer

Detalles Bibliográficos
Autores principales:	Christensen, Ditte S., Birkbak, Nicolai J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030149/ https://www.ncbi.nlm.nih.gov/pubmed/36944191 http://dx.doi.org/10.18632/oncotarget.28379

Ejemplares similares

Computational Analysis Reveals the Temporal Acquisition of Pathway Alterations during the Evolution of Cancer
por: Ahrenfeldt, Johanne, et al.
Publicado: (2022)

Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer
por: Abbosh, C, et al.
Publicado: (2018)

The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy
por: Ahrenfeldt, Johanne, et al.
Publicado: (2023)

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel
por: Kisistók, Judit, et al.
Publicado: (2023)

Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer
por: Sokač, Mateo, et al.
Publicado: (2022)

Evolution of resistance to thyroid cancer therapy
por: Nucera, Carmelo
Publicado: (2016)

Genome Evolution
por: Makałowska, Izabela, et al.
Publicado: (2010)

Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays
por: Lüftner, Diana
Publicado: (2022)

Foreword Special Issue Genomic Instability in Tumor Evolution and Therapy Response
por: Mitxelena, Jone, et al.
Publicado: (2023)

Comparative Genomics and Genome Evolution
por: Das, Sabyasachi, et al.
Publicado: (2012)

Driving cancer evolution
por: Fitzgerald, Devon M, et al.
Publicado: (2017)

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
por: McGranahan, Nicholas, et al.
Publicado: (2017)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives
por: Tang, Wen‐Fang, et al.
Publicado: (2021)

The Stability and Evolution of Genes and Genomes
por: Viggiano, Luigi, et al.
Publicado: (2023)

Welcome to Genome Biology and Evolution
por: Gojobori, Takashi, et al.
Publicado: (2009)

Genome and transcriptome mechanisms driving cephalopod evolution
por: Albertin, Caroline B., et al.
Publicado: (2022)

Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with (177)Lu-PSMA radioligand therapy
por: von Eyben, Finn Edler, et al.
Publicado: (2020)

Metastatic Colorectal Cancer
por: Passardi, Alessandro, et al.
Publicado: (2021)

When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?
por: Hardman, Morgan, et al.
Publicado: (2023)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy
por: Smolkova, Bozena, et al.
Publicado: (2022)

Computational optimisation of targeted DNA sequencing for cancer detection
por: Martinez, Pierre, et al.
Publicado: (2013)

Latency and interval therapy affect the evolution in metastatic colorectal cancer
por: Nikbakht, Hamid, et al.
Publicado: (2020)

Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer
por: Kloosterman, Wigard P, et al.
Publicado: (2011)

Paving the Way to Unveil the Diversity and Evolution of Phage Genomes
por: Reyes, Alejandro, et al.
Publicado: (2020)

Special Issue “Viral and Host Factors Driving the Emergence and the Evolution of the SARS-CoV-2 and Other Coronaviruses”
por: Ronfort, Corinne
Publicado: (2022)

Evolution of Guidelines for Testosterone Replacement Therapy
por: Park, Hyun Jun, et al.
Publicado: (2019)

Genome Biology and Evolution
Publicado: (2009)

Genome Biology and Evolution
Publicado: (2010)

PHIPing along: Evolution of PHIP as a cancer biomarker and a target for therapy
por: Kashani-Sabet, Mohammed, et al.
Publicado: (2018)

Red patches during bladder cancer surveillance: to biopsy or not to biopsy?
por: Drejer, Ditte, et al.
Publicado: (2018)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

Editor’s Report for Genome Biology and Evolution, 2013
por: Martin, Bill, et al.
Publicado: (2013)

Chromosome-Centric View of Genome Organization and Evolution
por: Sharakhova, Maria, et al.
Publicado: (2021)

The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent
por: Jutzy, Jessica M. S., et al.
Publicado: (2018)

Local therapy in patients with metastatic prostate cancer: a new standard of care?
por: Harper, Benjamin, et al.
Publicado: (2019)

Evolution of intravitreal therapy for retinal and macular disorders
por: Panos, Georgios D.
Publicado: (2018)

Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Sternberg, Cora N
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qjmj093pftv0h3n48l6posnnel